Regeneron Q3'26 earnings preview lists revenue estimate
Regeneron is scheduled to report Q3'26 results on October 30 before the market opens. Revenue and EPS estimates are provided.
Regeneron Pharmaceuticals, Inc. (REGN) is scheduled to report Q3'26 results on October 30 before the market opens. The release is expected at 6:30 AM ET (10:30 AM UTC). For Q3'26, revenue is estimated at 4.56 billion USD, while earnings per share (EPS) are anticipated at 16.37 USD.